Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CibusCBUS +0.52%59 EV-to-OCF is -2.98 as of Jul. 29, 2026. GuruFocus rates CBUS with a GF Score™ of 59/100 and a GF Value™ of $2.01 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,408 Biotechnology companies, Cibus ranks worse than 51.78% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Cibus's Enterprise Value is $149.87 Mil.
Cibus's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-50.25 Mil. Therefore, Cibus's EV-to-OCF for today is -2.98.
The historical rank and industry rank for Cibus's EV-to-OCF or its related term are showing as below:
CBUS'
s EV-to-OCF Range Over the Past 10 Years
Min: -73.96 Med: -4.02 Max: -0.55
Current: -2.98
During the past 11 years, the highest EV-to-OCF of Cibus was -0.55. The lowest was -73.96. And the median was -4.02.
CBUS's EV-to-OCF is ranked worse than 51.78% of 1408
companies
in the Biotechnology industry
Industry Median: -3.235
vs CBUS: -2.98
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-29), Cibus's stock price is $1.93.
Cibus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.970. Therefore, Cibus's PE Ratio (TTM) for today is At Loss.
Cibus (NAS:CBUS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cibus's share price for today is $1.93.
Cibus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.970.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cibus EV-to-OCF Related Terms
Cibus EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Cibus's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Cibus's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cibus EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cibus's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Cibus's EV-to-OCF falls into.
Cibus's current Enterprise Value is $149.87 Mil.
Cibus's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-50.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cibus (CBUS) has a EV-to-OCF of -2.98 as of Jul. 29, 2026. According to the industry distribution chart, Cibus ranks #729 out of 1408 companies in the Biotechnology industry, placing it in the top 51.8%.
Is Cibus' EV-to-OCF too high?
Cibus' current EV-to-OCF is -2.98. Based on the distribution chart, Cibus ranks #729 out of 1408 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Cibus has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cibus' EV-to-OCF compare to GNLX and ANIX?
According to the Biotechnology industry distribution chart, Cibus ranks #729 out of 1408 companies for EV-to-OCF. This places Cibus in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Cibus's current EV-to-OCF is -2.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cibus stock overvalued right now?
Based on GuruFocus' analysis, Cibus (CBUS) is currently considered Fairly Valued. The stock's GF Value™ is $2.01, compared to a current price of $1.93 — trading 4% below its estimated fair value. The current EV-to-OCF is -2.98. Cibus' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Cibus (CBUS), the current EV-to-OCF is -2.98 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cibus (CBUS) Overvalued in 2026?
Based on GuruFocus' analysis, Cibus stock appears to be undervalued.
The current stock price of $1.93 is trading 4% below its estimated GF Value™ of $2.01.
GuruFocus considers Cibus to be Fairly Valued.
Key valuation signals for CBUS:
EV-to-OCF: -2.98
GF Value™: $2.01 vs. price of $1.93 (4% below fair value)
No single metric tells the full story. See the CBUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
59GF Score
Get the complete analysis for CBUS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBUS has been successfully added to your 
